Levetiracetam in 0 recalled over sterility concerns
- Recall date
- March 27, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- AuroMedics Pharma LLC recalls Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL), For Intravenous Infusion Only, Distribut…
- Recall number
- D-0705-2018
- FDA classification
- Class II
- Brand / firm
- AuroMedics Pharma LLC
- Sold / distributed
- US Nationwide
Why it was recalled
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL), For Intravenous Infusion Only, Distributed By: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-246-47.
Get recall alerts
Free email alert whenever AuroMedics Pharma LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: AuroMedics Pharma LLC